je.st
news
MediciNova's Ibudilast And The Phase IIb Trial Offer Steady Outlook
2016-01-19 02:56:44| Biotech - Topix.net
I/we have no positions in any stocks mentioned, but may initiate a long position in MNOV over the next 72 hours. I wrote this article myself, and it expresses my own opinions.
Tags: offer
trial
phase
outlook
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||